• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1-10-100:统一目标,调动全球对抗微生物药物耐药性的行动。

1-10-100: Unifying goals to mobilize global action on antimicrobial resistance.

机构信息

Global Strategy Lab, Dahdaleh Institute for Global Health Research, York University, 4700 Keele Street, Dahdaleh Building 2120, Toronto, M3J 2S5, Canada.

School of Global Health, Faculty of Health, York University, Toronto, M3J 2S5, Canada.

出版信息

Global Health. 2024 Aug 27;20(1):66. doi: 10.1186/s12992-024-01070-8.

DOI:10.1186/s12992-024-01070-8
PMID:39187834
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11348599/
Abstract

The Bellagio Group for Accelerating AMR Action met in April 2024 to develop the ambitious but achievable 1-10-100 unifying goals to galvanize global policy change and investments for antimicrobial resistance mitigation: 1 Health; 10 million lives saved; and 100% sustainable access to effective antimicrobials. High profile political goals such as the Paris Agreement's objective to keep global warming well below 2° Celsius compared to pre-industrial levels, UNAIDS' 90-90-90 goal, and the Sustainable Development Goals challenge global norms, direct attention towards relevant activities, and serve an energizing function to motivate action over an extended period of time. The 1-10-100 unifying goals propose to unite the world through a One Health approach to safeguard human health, animal welfare, agrifood systems, and the environment from the emergence and spread of drug-resistant microbes and infections; save over 10 million lives by 2040 through concerted efforts to prevent and appropriately treat infections while preserving the vital systems and services that depend on sustained antimicrobial effectiveness; and commit to ensuring that antimicrobials are available and affordable for all, used prudently, and secured for the future through innovation. Compared to existing technical targets, these unifying goals offer advantages of focusing on prevention, encouraging multisectoral action and collaboration, promoting health equity, recognizing the need for innovation, and integrating with Sustainable Development Goals. By committing to 1 Health, 10 million lives saved, and 100% sustainable access to effective antimicrobials, we can protect lives and livelihoods today and safeguard options for tomorrow.

摘要

贝里佐集团为加速 AMR 行动于 2024 年 4 月召开会议,制定了雄心勃勃但可实现的 1-10-100 统一目标,以推动全球政策变革和投资,减轻抗菌药物耐药性:1 健康;挽救 1000 万人的生命;以及 100%可持续获得有效抗菌药物。高知名度的政治目标,如《巴黎协定》将全球升温控制在远低于工业化前水平 2 摄氏度以内的目标、联合国艾滋病规划署 90-90-90 目标以及可持续发展目标,挑战全球规范,将注意力引向相关活动,并具有激励作用,促使人们在较长时间内采取行动。1-10-100 统一目标提议通过“同一健康”方法将世界团结起来,保护人类健康、动物福利、农业食品系统和环境免受耐药微生物和感染的出现和传播;通过协调努力预防和适当治疗感染,同时保护依赖持续抗菌效果的重要系统和服务,到 2040 年挽救超过 1000 万人的生命;并承诺确保所有人都能获得和负担得起抗菌药物,谨慎使用抗菌药物,并通过创新确保未来的供应。与现有技术目标相比,这些统一目标具有注重预防、鼓励多部门行动和合作、促进健康公平、认识到创新必要性以及与可持续发展目标相整合的优势。通过承诺实现“同一健康”、挽救 1000 万人的生命和 100%可持续获得有效抗菌药物,我们可以保护今天的生命和生计,并为明天的选择提供保障。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/976b/11348599/ea4bb4c8858c/12992_2024_1070_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/976b/11348599/ea4bb4c8858c/12992_2024_1070_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/976b/11348599/ea4bb4c8858c/12992_2024_1070_Fig1_HTML.jpg

相似文献

1
1-10-100: Unifying goals to mobilize global action on antimicrobial resistance.1-10-100:统一目标,调动全球对抗微生物药物耐药性的行动。
Global Health. 2024 Aug 27;20(1):66. doi: 10.1186/s12992-024-01070-8.
2
Tuberculosis结核病
3
The 2023 Latin America report of the Countdown on health and climate change: the imperative for health-centred climate-resilient development.《2023年健康与气候变化倒计时拉丁美洲报告:以健康为中心的气候适应型发展的必要性》
Lancet Reg Health Am. 2024 Apr 23;33:100746. doi: 10.1016/j.lana.2024.100746. eCollection 2024 May.
4
AMR and Sustainable Development Goals: at a crossroads.抗微生物药物耐药性和可持续发展目标:处在十字路口。
Global Health. 2024 Oct 17;20(1):73. doi: 10.1186/s12992-024-01046-8.
5
Ensuring progress on sustainable access to effective antibiotics at the 2024 UN General Assembly: a target-based approach.确保在 2024 年联合国大会上实现可持续获得有效抗生素的进展:基于目标的方法。
Lancet. 2024 Jun 8;403(10443):2551-2564. doi: 10.1016/S0140-6736(24)01019-5. Epub 2024 May 23.
6
[Antimicrobial resistance: it is a global crisis, "a slow tsunami"].[抗微生物药物耐药性:这是一场全球危机,“一场缓慢的海啸”]
Ig Sanita Pubbl. 2019 Nov-Dec;75(6):429-450.
7
The Minderoo-Monaco Commission on Plastics and Human Health.美诺集团-摩纳哥基金会塑料与人体健康委员会
Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023.
8
Antimicrobial Resistance (AMR).抗微生物药物耐药性(AMR)。
Br J Biomed Sci. 2023 Jun 28;80:11387. doi: 10.3389/bjbs.2023.11387. eCollection 2023.
9
Adopting a Global AMR Target within the Pandemic Instrument Will Act as a Catalyst for Action.在大流行防范与应对基金内采用全球抗微生物药物耐药性目标将作为行动的催化剂。
J Law Med Ethics. 2022;50(S2):64-70. doi: 10.1017/jme.2022.101.
10
Tackling the threat of antimicrobial resistance: from policy to sustainable action.应对抗菌药物耐药性威胁:从政策到可持续行动。
Philos Trans R Soc Lond B Biol Sci. 2015 Jun 5;370(1670):20140082. doi: 10.1098/rstb.2014.0082.

引用本文的文献

1
Targeting Siderophore Biosynthesis to Thwart Microbial Growth.靶向铁载体生物合成以阻止微生物生长。
Int J Mol Sci. 2025 Apr 11;26(8):3611. doi: 10.3390/ijms26083611.
2
Intergovernmental or fully independent? Designing a scientific panel on evidence for action against antimicrobial resistance.政府间性质还是完全独立?设计一个关于抗微生物药物耐药性应对行动证据的科学小组。
PLOS Glob Public Health. 2025 Jan 3;5(1):e0004039. doi: 10.1371/journal.pgph.0004039. eCollection 2025.
3
Antibiotic Use and Antimicrobial Resistance: A Global Public Health Crisis.

本文引用的文献

1
Ensuring progress on sustainable access to effective antibiotics at the 2024 UN General Assembly: a target-based approach.确保在 2024 年联合国大会上实现可持续获得有效抗生素的进展:基于目标的方法。
Lancet. 2024 Jun 8;403(10443):2551-2564. doi: 10.1016/S0140-6736(24)01019-5. Epub 2024 May 23.
2
Antimicrobial resistance and the great divide: inequity in priorities and agendas between the Global North and the Global South threatens global mitigation of antimicrobial resistance.抗微生物药物耐药性和巨大鸿沟:全球北方和全球南方在优先事项和议程上的不平等,威胁到全球对抗微生物药物耐药性的缓解。
Lancet Glob Health. 2024 Mar;12(3):e516-e521. doi: 10.1016/S2214-109X(23)00554-5. Epub 2024 Jan 23.
3
抗生素使用与抗菌药物耐药性:一场全球公共卫生危机。
Antibiotics (Basel). 2024 Sep 21;13(9):900. doi: 10.3390/antibiotics13090900.
Antimicrobial Resistance Must Be Included in the Pandemic Instrament to Ensure Future Global Pandemic Readiness.
抗菌药物耐药性必须纳入大流行应对工具中,以确保未来全球对大流行的防范能力。
J Law Med Ethics. 2022;50(S2):9-16. doi: 10.1017/jme.2022.74.
4
Adopting a Global AMR Target within the Pandemic Instrument Will Act as a Catalyst for Action.在大流行防范与应对基金内采用全球抗微生物药物耐药性目标将作为行动的催化剂。
J Law Med Ethics. 2022;50(S2):64-70. doi: 10.1017/jme.2022.101.
5
One Health: A new definition for a sustainable and healthy future.同一健康:可持续健康未来的新定义。
PLoS Pathog. 2022 Jun 23;18(6):e1010537. doi: 10.1371/journal.ppat.1010537. eCollection 2022 Jun.
6
Taking stock of global commitments on antimicrobial resistance.评估全球对抗微生物药物耐药性的承诺。
BMJ Glob Health. 2022 May;7(5). doi: 10.1136/bmjgh-2021-008159.
7
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
8
Making Use of Existing International Legal Mechanisms to Manage the Global Antimicrobial Commons: Identifying Legal Hooks and Institutional Mandates.利用现有国际法律机制管理全球抗菌药物共同资源:确定法律衔接点和机构任务。
Health Care Anal. 2023 Mar;31(1):9-24. doi: 10.1007/s10728-020-00393-y.
9
Antimicrobial Resistance: Implications and Costs.抗菌药物耐药性:影响与成本
Infect Drug Resist. 2019 Dec 20;12:3903-3910. doi: 10.2147/IDR.S234610. eCollection 2019.